Industry Partner News - Biweekly newsletter of the International Cytokine & Interferon Society

ELISA Kits and Real-World Challenges

September 30, 2024

Contributed by Alok Pandey, Ph.D., VP Biomarker & Translational Science, PBL Assay Science When it comes to ELISA kits used for the detection of protein biomarkers, one observation we have made at PBL Assay Science—over and over again—is that not all assays are created equal. From our 30+ years of [READ MORE]

Meet the 2024 ICIS-Luminex John R. Kettman Award Winner: Laura K. Mackay, Ph.D.

September 30, 2024

Meet Laura Mackay, Ph.D., Professor at The University of Melbourne and Immunology Theme Lead at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. She completed her Ph.D. in 2009 under the supervision of Professor Alan Rickinson at The University of Birmingham (UK), and postdoctoral training (2009-2015) with Professor Francis Carbone at The University of Melbourne. [READ MORE]

ELISA Kits and Real-World Challenges

September 30, 2024

Photo of antique microscope and science books

Celebrating Cytokine and Interferon Anniversaries

September 30, 2024

We are excited to recognize two historic milestones that resonate deeply with the International Cytokine and Interferon Society: the 50th anniversary of the term “cytokine” and the 70th anniversary of the introduction of “Interferons.” Contributed by Valeriya Smaliy and Susan Carpenter, Ph.D., University of California at Santa Cruz It was [READ MORE]

Clinical Trials

September 30, 2024

Clinical Trials of interest to cytokine & interferon researchers. Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections ClinicalTrials.gov ID NCT06363370 Sponsor Kexing Biopharm Co., Ltd. Information provided by Kexing Biopharm Co., Ltd. (Responsible Party) Last Update Posted 2024-04-12 Mechanisms of Interferon Gamma-primed [READ MORE]

Share this: